Antimicrobial resistance has been presented as a highly prevailing condition.
Background
Antimicrobial resistance is emerging as a prevalent condition, significantly among the patients of urinary tract infections (UTIs). It has been found to be prevalent regardless of the age group of the patients. 1 Organisms causing the UTIs enter the urinary tract system from environment through urethra and bladder and travel upward via urinary orifice. Eventually, these infections occur more commonly among females than males, due to the differences in anatomical features. 2 Pathogenesis of urine infections tend to vary from one patient to another. The variation usually depends on the attributes of age, gender, sexual activities, bathroom habits, catheter application, clinical setting, and exposure of the patient to antimicrobial agents in the past. 1 Resistance to antimicrobial agents in the cases of urine infections has been increasing significantly. The variation has been noted to differ according to the regional and geographical settings of the patients. 2, 3 Thus, it has been deemed necessary to collect and present the significant information concerning the course of action as offered by the etiological factors of UTIs, with which they express resistance to the treatment modalities. 4 Urine infection has been recognized as the most prevalent form of infection that appears to range from asymptomatic occurrence to severity of indications that may even cause sepsis in the organs. Among all the hospital acquired infections, UTIs are the second most common cause of hospital related morbidity and deaths. 5 It has been observed that majority of the urine infections are infested by the influence of gram negative bacteria. The most common pathological agent causing UTIs is identified as Escherichia coli. Other types of gram negative bacteria may also include Klebsiella species, Pseudomonas aeruginosa, Acinetobacter, Proteus mirabilis, and Serratia. 5, 6 These urinary pathogens are kept under serious consideration to identify the antimicrobial resistance towards these agents. Limiting response to the condition due to the expression of resistance by these etiological factors is considered as a major contributing element to the healthcare expenses. According to Grandy, Fox & Hardy (2013) , around 150 million cases of urine infections will be reported in a year, from around the world. It has been recorded that about 20 per cent of males may experience the symptoms of urinary tract infections; while, half of the females will experience the symptoms of urinary tract infections once in life. 7 It is important to realize the associated situations of urinary disorders as the infestation evidently tends to recur in the patients. The identification is crucial as the chronic influence can cause pyelonephritis and may also lead to renal failure. 7 The rising prevalence of antimicrobial resistance among the patients of urine infections have been emerging as a challenge in the urology field. The entity has suppressed the success results of treatment with the antibiotics; therefore, the degree of recurrence is also increasing in the clinical setting. Modification in the expression of uropathogens is responsible for building resistance towards a specific drug. Recurrence, along with resistance, has presented serious setbacks in managing and treating the UTIs. It is presumed that if resistance is reduced among the urine infection pathogens, recurrence can also be managed. It is necessary to attain the knowledge of etiological factors, associated with the disease and their association with the drug expression to remove the clinical setbacks. 8 The purpose of the study is to acquire knowledge regarding the antimicrobial resistance patterns of the etiological agents of urinary tract infections amongst the children in Saudi Arabia. The study has presented the knowledge that can assist to develop better treatment alternatives for the UTIs. It is a necessary aspect as the persistence of urine infections can lead to chronic conditions like renal scarring, hypertension, and end stage renal failure. 3 
Method

Study design
A retrospective population-based epidemiological study has been designed for the fulfilment of set objectives. The study has been conducted for the period of one year. The children with the clinical diagnosis of urinary tract infection, presenting at the clinical setting of King Abdulaziz University Hospital, Saudi Arabia, have been assessed from the year 2016-2017.
Inclusion and exclusion criteria
The data of only those patients was taken, who have been provided with the clinical diagnosis of urinary tract infections by their doctors. It was also noted that further referred for the assessment and treatment has been provided. All the participants have been selected from the patient database of the selected clinical settings. Patients with any comorbidity and at stage of chronic condition have been excluded from the study.
Data collection
Data for all the patients has been collected for the demographic and clinical parameters. Demographic factors included age and gender. Clinical paradigms have included the type of drug resistance, congenital anomalies, and frequency of urinary tract infections, frequency of episodes, atypical features of urine infections, hydronephrosis, and the degree of reflux.
Identification and estimation of uropathogens
A surface streak procedure was performed to isolate uropathogens through calibrated loops for the semiquantitative method. The samples were incubated aerobically for 24 hours at 37 degrees centigrade. The negative samples were further incubated for 48 hours. In a sample, if a single organism was cultures at the concentration of ≥105cfu/ml, then it was termed positive for UTI.
Ethical consideration
Ethical approval for the study was obtained from the Ethical Review Board of King Abdulaziz University Hospital, Saudi Arabia, before the commencement of the protocol.
Statistical analysis
All the collected information has been coded and fed into the data sheets. Correlation analysis was performed on the recorded parameters for determining the association of urine infection and its etiologic factors with drug resistance. Data has been analysed through Statistical Package for the Social Science (SPSS).
Results
The study has recruited 63 participants on the basis of inclusion criteria. Among these, majority were males with the prevalence of 54 per cent (n=34); while females were 46 per cent (n=29). The prevalence of UTI was increased among majority of the participants under the age of two years with the prevalence of 50.8 per cent (n=32), then children of two years with 34.9 per cent (n=22); and older than 2 years with 14.3 per cent (n=9). Table 1 has displayed the physical attributes as recorded for the patients of UTI. Table 2 has presented the clinical observations for the study group. Table 3 has displayed the treatment response and resistance towards antibiotic drugs. 
Discussion
The study has extensively studied the clinical attributes of patients, who have been suffering from urine infections. Outcomes have provided data to perform a comparative analysis on the incidence of antimicrobial resistance as expressed for the pathogens, causing urine infections. It has been asserted by several studies that the incidence of urinary tract infections tends to be higher among females as compared to males. [9] [10] [11] The results of present study have presented the same prevalence. Females contract the urinary infections more conveniently due to the shorter distance of urethra to anus. 12 On the other hand, the prostatic fluid consists of substances that express antimicrobial activities, which decreases the susceptibility among males to contract the infections. 13 Intervention with antimicrobial drugs has been rapidly increasing around the world to compete with the treatment of urine infections. The widespread usage has led to an abuse of drug globally. The modality has exhausted the human resistance model in such a way that the infectious pathogens have evolved to express resistance towards the administered drugs. It has been observed with time that drug resistance has associations with the patterns of microorganisms. 14 Prevention has identified the categorization of bacterial isolates in the form of urgent and serious threats. These isolates have been known to impose serious clinical risk and economic burden on the health care system and pateints. 16 Multidrug resistance has been reported with high prevalence in the study conducted by Chang et al. Multidrug therapy is mainly induced in the cases of infections that have been known to be significant yet expensive in treating the diseases. Despite of extensive researches, particular driving processes for the bacterial agents have not been recorded well. Lack of knowledge leads to the administration of either multiple intervention of drugs or abused administration. 17 Ciprofloxacin are synthetic antimicrobials that have been facing an emerging resistance from the bacteria causing urine infections. Unlike multidrug resistance, the process of resistance in ciprofloxacin has been studied. It has been comprehended that it occurs with the genetic mutations and acquisition of genes conferring to gene resistance. 18 Recurrence of UTIs have been further determined as a strong factor, contributing to the repeatedly occurring infections and sensitivity to antimicrobial treatment. These are further influenced by the intracellular reservoirs of bacterial isolates, lining the mucosal wall of bladder. Consideration of such pathological factors has been presumed to have a strong role in the clinical aspects of the infections and resistance. A study tried for creating surveillance data on antibiotic resistance, type of infection, and consumption of antibiotic among the patients. 19 The results showed increased resistance rates for majority of the uropathogens against the antibiotics, along with the multidrug resistance. Another study conducted by Wagenlehner et al. 20 evaluated urology practice for controlling hospital infection and antibiotic consumption practice. The study helped in delivering data for appropriate antibiotic therapy among the hospitalized patients suffering from UTIs.
Conclusion
UTIs are identified as a burden to the healthcare facility, regardless of the fact that it is a treatable condition. Clinical management of urine infections has been presented as a major challenge due to the rising rate of antimicrobial resistance. Findings have presented that urinary tract infections have been expressing high rate of antimicrobial resistance. It is needed that researchers now look into modalities that can enhance the treatment actions of antimicrobial agents. 
